Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells: Autocrine modulation by prostacyclin

Journal of Cellular Physiology

Volumn 227, Issue 12, 2012, Pages 3847-3856

  Eligini, Sonia ^a   Songia, Paola ^a   Cavalca, Viviana ^a,b   Crisci, Mauro ^a   Tremoli, Elena ^a,b   Colli, Susanna ^b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACTIN; CYCLOOXYGENASE 2; F ACTIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38; NOCODAZOLE; PROSTACYCLIN; PROTEIN TYROSINE KINASE;

ACTIN FILAMENT; ARTICLE; AUTOCRINE EFFECT; CELL DISRUPTION; CELL LEVEL; CYTOARCHITECTURE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GAP JUNCTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MICROTUBULE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS FIBER; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOSKELETON; ENDOTHELIAL CELLS; EPOPROSTENOL; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; NOCODAZOLE; PACLITAXEL; SIGNAL TRANSDUCTION; TUBULIN MODULATORS;

EID: 84865432596     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24097     Document Type: Article

References (56)

1. Alfranca A, Iniguez MA, Fresno M, Redondo JM. 2006. Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases. Cardiovasc Res 70: 446-456.
2. Aljofan M, Ding H. 2010. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells. J Cell Physiol 222: 669-675.
3. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. 2010. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103: 40-55.
4. Birukova AA, Birukov KG, Smurova K, Adyshev D, Kaibuchi K, Alieva I, Garcia JG, Verin AD. 2004. Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J 18: 1879-1890.
5. Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR, Birukov KG. 2007. Prostaglandins PGE (2) and PGI (2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 313: 2504-2520.
6. Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. 2007. Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 292: L487-L499.
7. Boudreau RT, Hoskin DW. 2005. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: Lessons from the mast cell model system. Int Immunopharmacol 5: 1507-1518.
8. Bulin C, Albrecht U, Bode JG, Weber AA, Schrör K, Levkau B, Fischer JW. 2005. Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 84-89.
9. Bundey RA, Insel PA. 2006. Adenylyl cyclase 6 overexpression decreases the permeability of endothelial monolayers via preferential enhancement of prostacyclin receptor function. Mol Pharmacol 70: 1700-1707.
10. Chen FC, Ogut O. 2006. Decline of contractility during ischemia-reperfusion injury: Actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol 290: C719-C727.
11. Chen KD, Lai MT, Cho JH, Chen LY, Lai YK. 2000. Activation of p38 mitogen-activated protein kinase and mitochondrial Ca (2+)-mediated oxidative stress are essential for the enhanced expression of grp78 induced by the protein phosphatase inhibitors okadaic acid and calyculin A. J Cell Biochem 76: 585-595.
12. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. 2002. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296: 539-541.
13. Chouinard JA, Grenier G, Khalil A, Vermette P. 2008. Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp Cell Res 314: 3007-3016.
14. Churchman A, Baydoun AR, Hoffman R. 2007. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl)-thiophene (DuP-697). Eur J Pharmacol 573: 176-183.
15. Dalle-Donne I, Giustarini D, Rossi R, Colombo R, Milzani A. 2003. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 34: 23-32.
16. Debey S, Meyer-Kirchrath J, Schrör K. 2003. Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Role of transcription factors CREB and ICER. Biochem Pharmacol 65: 979-988.
17. 2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signalling. J Biol Chem 277: 45838-45846.
18. DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073.
19. Eligini S, Barbieri SS, Cavalca V, Camera M, Brambilla M, De Franceschi M, Tremoli E, Colli S. 2005. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovasc Res 65: 683-693.
20. Eligini S, Arenaz I, Barbieri SS, Faleri ML, Crisci M, Tremoli E, Colli S. 2009. Cyclooxygenase-2 mediates hydrogen peroxide-induced wound repair in human endothelial cells. Free Radic Biol Med 46: 1428-1436.
21. Essler M, Retzer M, Bauer M, Heemskerk JW, Aepfelbacher M, Siess W. 1999. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem 274: 30361-30364.
22. Fiaschi T, Cozzi G, Raugei G, Formigli L, Ramponi G, Chiarugi P. 2006. Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 281: 22983-22991.
23. Fitzgerald GA. 2004. Coxibs and cardiovascular disease. N Engl J Med 351: 1709-1711.
24. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vandekerckhove J, Gianazza E, Ghezzi P. 2002. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA 99: 3505-3510.
25. Fuchs E, Karakesisoglou I. 2001. Bridging cytoskeletal intersections. Genes Dev 15: 1-14.
26. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. 2005. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25: 136-146.
27. Gorovoy M, Niu J, Bernard O, Profirovic J, Minshall R, Neamu R, Voyno-Yasenetskaya T. 2005. LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells. J Biol Chem 280: 26533-26542.
28. Graness A, Cicha I, Goppelt-Struebe M. 2006. Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int 69: 1341-1349.
29. Kasza Z, Fetalvero KM, Ding M, Wagner RJ, Acs K, Guzman AK, Douville KL, Powell RJ, Hwa J, Martin KA. 2009. Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation. J Mol Cell Cardiol 46: 682-694.
30. Lee JSY, Gotlieb AI. 2005. Microtubules regulate aortic endothelial cell actin microfilament reorganization in intact and repairing monolayers. Histol Histopathol 20: 455-465.
31. Li YS, Haga JH, Chien S. 2005. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 38: 1949-1971.
32. Li HB, Ge YK, Zhang L, Zheng XX. 2006. Astragaloside IV improved barrier dysfunction induced by acute high glucose in human umbilical vein endothelial cells. Life Sci 79: 1186-1193.
33. Lin HP, Kulp SK, Tseng PH, Yang YT, Yang CC, Chen CS, Chen CS. 2004. Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms. Mol Cancer Ther 12: 1671-1680.
34. McMullen M, Keller R, Sussman M, Pumiglia K. 2004. Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23: 1275-1282.
35. Molony L, Armstrong L. 1991. Cytoskeletal reorganizations in human umbilical vein endothelial cells as a result of cytokine exposure. Exp Cell Res 196: 40-48.
36. Norata GD, Pirillo A, Pellegatta F, Inoue H, Catapano AL. 2004. Native LDL and oxidized LDL modulate cyclooxygenase-2 expression in HUVECs through a p38-MAPK, NF-kappaB, CRE dependent pathway and affect PGE2 synthesis. Int J Mol Med 14: 353-359.
37. Ohmori T, Yatomi Y, Okamoto H, Miura Y, Rile G, Satoh K, Ozaki Y. 2001. G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: Possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. J Biol Chem 276: 5274-5280.
38. Pahujaa M, Anikin M, Golberg GS. 2007. Phosphorylation of connexin43 induced by Src: Regulation of gap junctional communication between transformed cells. Exp Cell Res 313: 4083-4090.
39. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F. 2003. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem 278: 42588-42595.
40. Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM, Waterman-Storer CM. 2003. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 5: 599-609.
41. Rush DS, Kerstein MD, Bellan JA, Knoop SM, Mayeux PR, Hyman AL, Kadowitz PJ, McNamara DB. 1988. Prostacyclin, thromboxane A2, and prostaglandin E2 formation in atherosclerotic human carotid artery. Arterioscler Thromb Vasc Biol 8: 73-78.
42. Samarakoon R, Higgins PJ. 2002. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. J Cell Sci 115: 3093-3103.
43. Samarakoon R, Higgins CE, Higgins SP, Higgins PJ. 2009. Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption. Cell Signal 21: 986-995.
44. Sawyer SJ, Norvell SM, Ponik SM, Pavalko FM. 2001. Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton. Am J Physiol Cell Physiol 281: C1038-C1045.
45. Sehrawat S, Cullere X, Patel S, Italiano J, Jr., Mayadas TN. 2008. Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell 19: 1261-1270.
46. Slice LW, Walsh JH, Rozengurt E. 1999. Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter. J Biol Chem 274: 27562-27566.
47. Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM, Piemonte F. 2006. Protein glutathionylation in human central nervous system: Potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 83: 256-263.
48. Spector I, Braet F, Shochet NR, Bubb MR. 1999. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 47: 18-37.
49. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. 2000. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol Chem 275: 14838-14845.
50. Tar K, Birukova AA, Csortos C, Bakò E, Garcia JG, Verin AD. 2004. Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation. J Cell Biochem 92: 534-546.
51. Tar K, Csortos C, Czikora I, Olah G, Ma SF, Wadgaonakar R, Gergely P, Garcia JG, Verin AD. 2006. Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J Cell Biochem 98: 931-953.
52. Turini ME, DuBois RN. 2002. Cyclooxygenase-2: A therapeutic target. Annu Rev Med 53: 35-57.
53. Turner EC, Mulvaney EP, Reid HM, Kinsella BT. 2011. Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZ K1: Role in endothelial cell migration and angiogenesis. Mol Biol Cell 22: 2664-2679.
54. van Gorp RM, Broers JL, Reutelingsperger CP, Bronnenberg NM, van Dam-Mieras MC, Heemskerk JW. 1999. Peroxide-induced membrane blebbing in endothelial cells associated with glutathione oxidation but not apoptosis. Am J Physiol 277: C20-C28.
55. World Medical Association. 1997. World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35: 2-3.
56. Wu B, Decourt B, Zabidi MA, Wuethrich LT, Kim WH, Zhou Z, MacIsaac K, Suter DM. 2008. Microtubule-mediated Src tyrosine kinase trafficking in neuronal growth cones. Mol Biol Cell 19: 4611-4627.